NCAM1 and acute myeloid leukemia: The presence of myelomonocytic specific markers, such as CD13, CD15, CD33, myeloperoxidase (MPO), CD14, and CD64 is useful for establishing the diagnosis of CD56‐positive acute myeloid leukemia, first presenting in the skin.11